Effects of Non‐Aspirin Nonsteroidal Anti‐Inflammatory Drugs on Acute Intracerebral Hemorrhage
ABSTRACT Objective Despite celecoxib, a cyclooxygenase‐2 inhibitor, promoting functional recovery from intracerebral hemorrhage (ICH) by reducing inflammation‐mediated perihematomal edema in rat models, the evidence of its effects on patient outcomes remains limited.
Shin‐Joe Yeh+3 more
wiley +1 more source
Equity, diversity, and inclusion in developmental neuroscience: Practical lessons from community-based participatory research. [PDF]
La Scala S+4 more
europepmc +1 more source
Long‐Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History Comparisons
ABSTRACT Objectives This ongoing, open‐label extension study is evaluating the long‐term safety, tolerability, and efficacy of givinostat, a Class I and II histone deacetylase inhibitor, in patients with Duchenne muscular dystrophy (DMD). Methods The recruited patients completed one of two prior clinical studies (one Phase 2 and one Phase 3 [EPIDYS ...
Craig M. McDonald+74 more
wiley +1 more source
Ethical dimensions of translational developmental neuroscience research in autism. [PDF]
Manzini A+5 more
europepmc +1 more source
ABSTRACT Objective Recurrent high‐grade gliomas have a poor prognosis and limited therapeutic options. This study aimed to evaluate the safety and efficacy of SYHA1813, a dual inhibitor of VEGFR and CSF1R, in patients with recurrent high‐grade gliomas.
Zhuang Kang+16 more
wiley +1 more source
Neural Entrainment vs. Stimulus-Tracking: A Conceptual Challenge for Rhythmic Perceptual Stimulation in Developmental Neuroscience. [PDF]
Bánki A+3 more
europepmc +1 more source
Corrigendum to “Potential mechanism of cell death in the developing rat brain induced by propofol anesthesia”International Journal of Developmental Neuroscience 27(3) 279–287 (2009) [PDF]
Vesna Pešić+6 more
openalex +1 more source
Durability of Response to B‐Cell Maturation Antigen‐Directed mRNA Cell Therapy in Myasthenia Gravis
ABSTRACT Objective We report the 12‐month follow‐up outcomes from a Phase 2 clinical trial (NCT04146051) evaluating Descartes‐08, a BCMA‐directed RNA chimeric antigen receptor T‐cell (rCAR‐T) therapy for refractory generalized myasthenia gravis (MG).
Nizar Chahin+10 more
wiley +1 more source
Improving Executive Function and Its Neurobiological Mechanisms Through a Mindfulness‐Based Intervention: Advances Within the Field of Developmental Neuroscience [PDF]
Yi‐Yuan Tang+3 more
openalex +1 more source
Extreme evolutionary shifts in developmental timing establish the miniature
Kevin W. Conway+2 more
openalex +1 more source